TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to aprende más. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.
Learn about the important connection between cardiovascular health and rare kidney diseases in this educational session. Gain a better understanding of how these conditions are related, why heart health matters, and key considerations for managing your overall well-being. Whether you’re a patient, care partner, or healthcare professional, this session provides valuable information to help you stay informed and engaged in your care.
Visita nuestra página de Youtube
NephCure es una organización benéfica sin fines de lucro (501c3) registrada y exenta de impuestos. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. Todos los derechos reservados en todo el mundo. NephCure y el logotipo son marcas comerciales registradas a nivel federal de NephCure, Inc.
ES 
EN 
